| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 5.64e-06 | 22 | 32 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 7.40e-06 | 24 | 32 | 3 | GO:0120283 | |
| GeneOntologyMolecularFunction | D2 dopamine receptor binding | 5.20e-05 | 7 | 32 | 2 | GO:0031749 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 8.82e-05 | 288 | 32 | 5 | GO:0016757 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 3.46e-04 | 211 | 32 | 4 | GO:0016758 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate binding | 4.68e-04 | 95 | 32 | 3 | GO:0005546 | |
| GeneOntologyMolecularFunction | dopamine receptor binding | 7.89e-04 | 26 | 32 | 2 | GO:0050780 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate binding | 9.47e-04 | 121 | 32 | 3 | GO:1902936 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 2.16e-03 | 43 | 32 | 2 | GO:0008307 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 2.79e-03 | 49 | 32 | 2 | GO:0005547 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 3.91e-03 | 199 | 32 | 3 | GO:1901981 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding from presynaptic endocytic zone membrane | 5.55e-07 | 11 | 32 | 3 | GO:0016185 | |
| GeneOntologyBiologicalProcess | synaptic vesicle budding | 1.52e-06 | 15 | 32 | 3 | GO:0070142 | |
| GeneOntologyBiologicalProcess | vesicle scission | 6.99e-06 | 3 | 32 | 2 | GO:0099050 | |
| GeneOntologyBiologicalProcess | synaptic vesicle transport | 7.97e-05 | 54 | 32 | 3 | GO:0048489 | |
| GeneOntologyBiologicalProcess | synaptic vesicle localization | 1.80e-04 | 71 | 32 | 3 | GO:0097479 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 2.29e-04 | 78 | 32 | 3 | GO:0001917 | |
| GeneOntologyCellularComponent | myosin filament | 6.66e-04 | 25 | 32 | 2 | GO:0032982 | |
| GeneOntologyCellularComponent | M band | 1.03e-03 | 31 | 32 | 2 | GO:0031430 | |
| GeneOntologyCellularComponent | microtubule | 1.20e-03 | 533 | 32 | 5 | GO:0005874 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.73e-03 | 1179 | 32 | 7 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.80e-03 | 1187 | 32 | 7 | GO:0099081 | |
| Domain | Dynamin_central | 9.11e-08 | 6 | 32 | 3 | IPR000375 | |
| Domain | Dynamin_M | 9.11e-08 | 6 | 32 | 3 | PF01031 | |
| Domain | Dynamin_GTPase_CS | 9.11e-08 | 6 | 32 | 3 | IPR019762 | |
| Domain | GED | 9.11e-08 | 6 | 32 | 3 | SM00302 | |
| Domain | GED_dom | 9.11e-08 | 6 | 32 | 3 | IPR020850 | |
| Domain | GED | 9.11e-08 | 6 | 32 | 3 | PF02212 | |
| Domain | GED | 9.11e-08 | 6 | 32 | 3 | IPR003130 | |
| Domain | GED | 9.11e-08 | 6 | 32 | 3 | PS51388 | |
| Domain | G_DYNAMIN_1 | 1.59e-07 | 7 | 32 | 3 | PS00410 | |
| Domain | DYNc | 1.59e-07 | 7 | 32 | 3 | SM00053 | |
| Domain | G_DYNAMIN_dom | 1.64e-06 | 14 | 32 | 3 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 1.64e-06 | 14 | 32 | 3 | PS51718 | |
| Domain | Dynamin_SF | 2.05e-06 | 15 | 32 | 3 | IPR022812 | |
| Domain | Dynamin_GTPase | 2.05e-06 | 15 | 32 | 3 | IPR001401 | |
| Domain | Dynamin_N | 2.05e-06 | 15 | 32 | 3 | PF00350 | |
| Domain | PH | 4.08e-05 | 229 | 32 | 5 | PF00169 | |
| Domain | PH | 1.02e-04 | 278 | 32 | 5 | SM00233 | |
| Domain | PH_DOMAIN | 1.04e-04 | 279 | 32 | 5 | PS50003 | |
| Domain | PH_domain | 1.06e-04 | 280 | 32 | 5 | IPR001849 | |
| Domain | - | 4.95e-04 | 391 | 32 | 5 | 2.30.29.30 | |
| Domain | PH_dom-like | 7.31e-04 | 426 | 32 | 5 | IPR011993 | |
| Domain | GDS_CDC24_CS | 2.03e-03 | 39 | 32 | 2 | IPR001331 | |
| Domain | DH_1 | 5.20e-03 | 63 | 32 | 2 | PS00741 | |
| Domain | RhoGEF | 6.04e-03 | 68 | 32 | 2 | SM00325 | |
| Domain | DH_2 | 6.39e-03 | 70 | 32 | 2 | PS50010 | |
| Domain | RhoGEF | 6.39e-03 | 70 | 32 | 2 | PF00621 | |
| Domain | DH-domain | 6.57e-03 | 71 | 32 | 2 | IPR000219 | |
| Domain | - | 6.57e-03 | 71 | 32 | 2 | 1.20.900.10 | |
| Domain | Kinase-like_dom | 1.32e-02 | 542 | 32 | 4 | IPR011009 | |
| Pathway | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | 1.77e-06 | 14 | 25 | 3 | M10122 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 3.68e-05 | 37 | 25 | 3 | MM15102 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 8.60e-05 | 49 | 25 | 3 | M891 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 9.70e-05 | 51 | 25 | 3 | M39457 | |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 1.64e-04 | 11 | 25 | 2 | MM14732 | |
| Pathway | REACTOME_GAP_JUNCTION_DEGRADATION | 1.97e-04 | 12 | 25 | 2 | M15243 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.29e-04 | 68 | 25 | 3 | MM14968 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 6.31e-04 | 96 | 25 | 3 | M16121 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.07e-03 | 261 | 25 | 4 | MM15676 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.09e-03 | 116 | 25 | 3 | MM14855 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.24e-03 | 121 | 25 | 3 | M872 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_4_TLR4_CASCADE | 1.27e-03 | 122 | 25 | 3 | MM14640 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.39e-03 | 126 | 25 | 3 | M705 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.65e-03 | 502 | 25 | 5 | MM14537 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 1.66e-03 | 134 | 25 | 3 | M3574 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 1.96e-03 | 142 | 25 | 3 | MM15499 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 2.08e-03 | 145 | 25 | 3 | M27753 | |
| Pubmed | Developmental expression of the dynamin family of mechanoenzymes in the mouse epididymis. | 7.07e-10 | 3 | 32 | 3 | 28395327 | |
| Pubmed | 7.07e-10 | 3 | 32 | 3 | 12383797 | ||
| Pubmed | 7.07e-10 | 3 | 32 | 3 | 12517701 | ||
| Pubmed | Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. | 7.07e-10 | 3 | 32 | 3 | 24046449 | |
| Pubmed | 7.07e-10 | 3 | 32 | 3 | 24273169 | ||
| Pubmed | 7.07e-10 | 3 | 32 | 3 | 12511974 | ||
| Pubmed | Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. | 2.83e-09 | 4 | 32 | 3 | 21689597 | |
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 22846998 | ||
| Pubmed | 7.07e-09 | 5 | 32 | 3 | 9722593 | ||
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 23640057 | ||
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 27251629 | ||
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 18602423 | ||
| Pubmed | 2.47e-08 | 7 | 32 | 3 | 15252009 | ||
| Pubmed | 3.95e-08 | 8 | 32 | 3 | 24282027 | ||
| Pubmed | 5.92e-08 | 9 | 32 | 3 | 23170932 | ||
| Pubmed | 8.45e-08 | 10 | 32 | 3 | 10398046 | ||
| Pubmed | 8.45e-08 | 10 | 32 | 3 | 23746204 | ||
| Pubmed | Plk2 attachment to NSF induces homeostatic removal of GluA2 during chronic overexcitation. | 2.56e-07 | 14 | 32 | 3 | 20802490 | |
| Pubmed | 4.77e-07 | 17 | 32 | 3 | 37042948 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 38641407 | ||
| Pubmed | Dynamin-mediated lipid acquisition is essential for Chlamydia trachomatis development. | 8.20e-07 | 2 | 32 | 2 | 25116793 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 34274446 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 11782545 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 24963135 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 24673776 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 21670293 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 16028072 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 22977254 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 26302298 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 22308498 | ||
| Pubmed | Dynamin 2-dependent endocytosis is essential for mouse oocyte development and fertility. | 8.20e-07 | 2 | 32 | 2 | 32065700 | |
| Pubmed | An intramolecular signaling element that modulates dynamin function in vitro and in vivo. | 8.20e-07 | 2 | 32 | 2 | 19515832 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 20700106 | ||
| Pubmed | Dynamin is primed at endocytic sites for ultrafast endocytosis. | 8.20e-07 | 2 | 32 | 2 | 35809574 | |
| Pubmed | 2.04e-06 | 27 | 32 | 3 | 19723784 | ||
| Pubmed | Presynaptic autophagy is coupled to the synaptic vesicle cycle via ATG-9. | 2.46e-06 | 3 | 32 | 2 | 35065714 | |
| Pubmed | SNX9 regulates dynamin assembly and is required for efficient clathrin-mediated endocytosis. | 2.46e-06 | 3 | 32 | 2 | 15703209 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 22371560 | ||
| Pubmed | Lipid droplet breakdown requires dynamin 2 for vesiculation of autolysosomal tubules in hepatocytes. | 2.46e-06 | 3 | 32 | 2 | 24145164 | |
| Pubmed | The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis. | 2.46e-06 | 3 | 32 | 2 | 32573516 | |
| Pubmed | The Eps15 C. elegans homologue EHS-1 is implicated in synaptic vesicle recycling. | 2.46e-06 | 3 | 32 | 2 | 11483962 | |
| Pubmed | Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase. | 2.46e-06 | 3 | 32 | 2 | 15895076 | |
| Pubmed | Coordinated actions of actin and BAR proteins upstream of dynamin at endocytic clathrin-coated pits. | 4.92e-06 | 4 | 32 | 2 | 20059951 | |
| Pubmed | Dynamin2 and cortactin regulate actin assembly and filament organization. | 4.92e-06 | 4 | 32 | 2 | 12419186 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 14709338 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 28621662 | ||
| Pubmed | Dynamin and endocytosis are required for the fusion of osteoclasts and myoblasts. | 4.92e-06 | 4 | 32 | 2 | 25287300 | |
| Pubmed | Proteomic identification of brain proteins that interact with dynein light chain LC8. | 7.93e-06 | 42 | 32 | 3 | 14760703 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 21169560 | ||
| Pubmed | Dynamin reduces Pyk2 Y402 phosphorylation and SRC binding in osteoclasts. | 8.19e-06 | 5 | 32 | 2 | 19380485 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 24970086 | ||
| Pubmed | Role of dynamin, synaptojanin, and endophilin in podocyte foot processes. | 1.23e-05 | 6 | 32 | 2 | 23187129 | |
| Pubmed | TTP specifically regulates the internalization of the transferrin receptor. | 1.23e-05 | 6 | 32 | 2 | 16325581 | |
| Pubmed | Abl family tyrosine kinases govern IgG extravasation in the skin in a murine pemphigus model. | 1.23e-05 | 6 | 32 | 2 | 31570755 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 10542231 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 18353773 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 25417109 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 22099461 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 15834155 | ||
| Pubmed | Dynamin genes Dnm1 and Dnm2 are located on proximal mouse chromosomes 2 and 9, respectively. | 2.94e-05 | 9 | 32 | 2 | 9143510 | |
| Pubmed | 4.49e-05 | 11 | 32 | 2 | 12456676 | ||
| Pubmed | Redundant and nonredundant organismal functions of EPS15 and EPS15L1. | 7.41e-05 | 14 | 32 | 2 | 30692166 | |
| Pubmed | 1.18e-04 | 103 | 32 | 3 | 21706016 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.39e-04 | 19 | 32 | 2 | 23281178 | |
| Pubmed | 1.87e-04 | 22 | 32 | 2 | 27146480 | ||
| Pubmed | 2.24e-04 | 24 | 32 | 2 | 19680556 | ||
| Pubmed | 2.67e-04 | 136 | 32 | 3 | 25429064 | ||
| Pubmed | 3.05e-04 | 28 | 32 | 2 | 24448406 | ||
| Pubmed | Many sequence variants affecting diversity of adult human height. | 3.09e-04 | 143 | 32 | 3 | 18391951 | |
| Pubmed | Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. | 5.65e-04 | 38 | 32 | 2 | 11756498 | |
| Pubmed | 7.23e-04 | 43 | 32 | 2 | 12376548 | ||
| Interaction | ZBBX interactions | 1.59e-05 | 31 | 32 | 3 | int:ZBBX | |
| Interaction | LYPD6 interactions | 1.92e-05 | 33 | 32 | 3 | int:LYPD6 | |
| Interaction | DNMBP interactions | 4.30e-05 | 124 | 32 | 4 | int:DNMBP | |
| Interaction | FER interactions | 6.77e-05 | 50 | 32 | 3 | int:FER | |
| Interaction | RPE interactions | 1.06e-04 | 58 | 32 | 3 | int:RPE | |
| Interaction | SNX33 interactions | 1.42e-04 | 64 | 32 | 3 | int:SNX33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 1.50e-03 | 325 | 32 | 3 | chr9q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q22 | 1.98e-03 | 94 | 32 | 2 | chr14q22 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.49e-03 | 206 | 27 | 3 | 682 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.34e-03 | 66 | 27 | 2 | 722 | |
| GeneFamily | Fibronectin type III domain containing | 2.36e-02 | 160 | 27 | 2 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.39e-02 | 161 | 27 | 2 | 593 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 200 | 32 | 4 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 200 | 32 | 4 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.74e-04 | 152 | 32 | 3 | eb7ff36792c3c54ac88cfe976f84016b70b1a1d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.92e-04 | 157 | 32 | 3 | a93866f051472506f1468f379c0d5313e02c9731 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 161 | 32 | 3 | 441ebd3c029861d833fbcf8a68fc740d9de8ef2f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 161 | 32 | 3 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-04 | 164 | 32 | 3 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 168 | 32 | 3 | ce9fae8b295c668b0959d5007a8bcd401d80e258 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.43e-04 | 170 | 32 | 3 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-04 | 170 | 32 | 3 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-04 | 170 | 32 | 3 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-04 | 170 | 32 | 3 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-04 | 171 | 32 | 3 | 584a095ddcbf78aa29527f84b46b5ad3e2edbaa9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-04 | 172 | 32 | 3 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-04 | 172 | 32 | 3 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.60e-04 | 174 | 32 | 3 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.69e-04 | 176 | 32 | 3 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-04 | 178 | 32 | 3 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.78e-04 | 178 | 32 | 3 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.82e-04 | 179 | 32 | 3 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | 3'_v3-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 2.87e-04 | 180 | 32 | 3 | b37ee81b792213d6595b4ec65d04bc35d83321c7 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.91e-04 | 181 | 32 | 3 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 2.91e-04 | 181 | 32 | 3 | 30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.96e-04 | 182 | 32 | 3 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.96e-04 | 182 | 32 | 3 | f231e86524b628e6e11ac33d5c34be99d454a92a | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.01e-04 | 183 | 32 | 3 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-04 | 183 | 32 | 3 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 3.06e-04 | 184 | 32 | 3 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.11e-04 | 185 | 32 | 3 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 3.11e-04 | 185 | 32 | 3 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.21e-04 | 187 | 32 | 3 | 406ff9327d3109fe1e251629c4c617b00a573dc2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-04 | 189 | 32 | 3 | 032f169e8ede653117919bf97c17f92043320b3c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-04 | 189 | 32 | 3 | 07208d32afca6f93207a2ac35b647b31a9f71b7c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.36e-04 | 190 | 32 | 3 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.36e-04 | 190 | 32 | 3 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.36e-04 | 190 | 32 | 3 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.41e-04 | 191 | 32 | 3 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.41e-04 | 191 | 32 | 3 | f9a46956778a8773d6656340ecf5d218376d79c2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.46e-04 | 192 | 32 | 3 | fee99ca7e658963acf968aa724ef8c96cfc00a5d | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.46e-04 | 192 | 32 | 3 | b73f24d1c55dfef1eb01c26da117dbf637ea080a | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.52e-04 | 193 | 32 | 3 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.52e-04 | 193 | 32 | 3 | 360079cbaa18b74e4a48c5de40844faca076e1a6 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.57e-04 | 194 | 32 | 3 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-04 | 195 | 32 | 3 | 5dc874641ad9537e4c1369825c1fb0a59f12a83d | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.62e-04 | 195 | 32 | 3 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.68e-04 | 196 | 32 | 3 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-04 | 196 | 32 | 3 | 1d94cecd378a829dd8014fc086d7fca48c953a91 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.68e-04 | 196 | 32 | 3 | aacec48285bcb7ccf1b538187071885e3602cc49 | |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.79e-04 | 198 | 32 | 3 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | mild-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.90e-04 | 200 | 32 | 3 | a195bc6784346f706d4cd5b740adac1d950ce88a | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| Drug | library 2 | 1.23e-08 | 19 | 32 | 4 | CID005270634 | |
| Drug | Go7874 | 5.50e-07 | 12 | 32 | 3 | CID005327863 | |
| Drug | AC1L9JXQ | 1.34e-05 | 33 | 32 | 3 | CID000446658 | |
| Drug | Asp-pro | 1.34e-05 | 104 | 32 | 4 | CID000170612 | |
| Drug | Spider Venoms | 1.91e-05 | 5 | 32 | 2 | ctd:D013111 | |
| Drug | NSC3364 | 2.20e-05 | 118 | 32 | 4 | CID000025439 | |
| Drug | fisetin | 2.41e-05 | 40 | 32 | 3 | CID005281614 | |
| Drug | 2gzl | 3.67e-05 | 46 | 32 | 3 | CID006102719 | |
| Drug | silibinin | 4.53e-05 | 285 | 32 | 5 | CID000005213 | |
| Drug | etorphine | 7.77e-05 | 59 | 32 | 3 | CID000026721 | |
| Drug | 1,3-di-o-tolylguanidine | 8.59e-05 | 61 | 32 | 3 | CID000007333 | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 1.05e-08 | 5 | 31 | 3 | DOID:0111223 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 1.05e-08 | 5 | 31 | 3 | DOID:0110197 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 1.05e-08 | 5 | 31 | 3 | DOID:11252 (implicated_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 2.30e-07 | 12 | 31 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 2.98e-07 | 13 | 31 | 3 | DOID:0112202 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.26e-05 | 43 | 31 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | rectum cancer | 8.96e-04 | 42 | 31 | 2 | EFO_1000657 | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 1.03e-03 | 45 | 31 | 2 | DOID:3525 (implicated_via_orthology) | |
| Disease | Thrombus | 1.07e-03 | 46 | 31 | 2 | C0087086 | |
| Disease | myopathy (implicated_via_orthology) | 1.17e-03 | 48 | 31 | 2 | DOID:423 (implicated_via_orthology) | |
| Disease | Thrombosis | 1.22e-03 | 49 | 31 | 2 | C0040053 | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 2.13e-03 | 65 | 31 | 2 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | calcium measurement | 4.05e-03 | 628 | 31 | 4 | EFO_0004838 | |
| Disease | Uterine leiomyoma | 4.13e-03 | 91 | 31 | 2 | HP_0000131 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FFEFYRLLHDARPKE | 731 | Q9Y6K1 | |
| KEHVFLPLIDMLIYF | 61 | Q7Z5M8 | |
| KEFPYRMNHILECEF | 126 | P24863 | |
| EYFFDRDPDMFRHVL | 81 | Q9NSA2 | |
| PQYLEMEFKERFVVH | 526 | Q8N201 | |
| FHERFPFELVKMEFD | 366 | Q05193 | |
| FHERFPFEIVKMEFN | 366 | Q9UQ16 | |
| LIKEDHNLHEPMYFF | 46 | Q9H339 | |
| EAFKIPIREFMNYFH | 726 | Q14432 | |
| FHERFPFELVKMEFD | 366 | P50570 | |
| GEKLMRFSYPDIHFD | 286 | Q9UKS7 | |
| DLYDIKYLPFEFMIF | 7311 | Q5VST9 | |
| YLPFFLMEKTLFLYH | 651 | Q9Y6A1 | |
| FYIMVDAFFKLPDIE | 111 | Q7Z4J2 | |
| AFEIDKMYTPLFFAR | 421 | Q9UK97 | |
| HVIRMYFLGFEAPEK | 346 | Q9NSI6 | |
| LEFYREHVKPLFNME | 251 | Q13867 | |
| PMQRHLFLYEKAIVF | 721 | P10911 | |
| FFRIKMYPVEDFEAS | 276 | Q5TBA9 | |
| DMYLETKRHIFPRFY | 1521 | Q9P225 | |
| MLRIKEPLHFFEDYF | 266 | Q8N7B9 | |
| ELFMEFRKFDLLFPR | 201 | Q9UNU6 | |
| LEAEFYFTHLIVMFK | 121 | Q9HB63 | |
| MFDIEYFRKDPRPFF | 296 | Q96EB6 | |
| VRMHLYPADFRFDKP | 166 | Q8NB15 | |
| AQVFPKYEEFMHRLA | 156 | Q8N2H3 | |
| PDLFKDIINMLFYHD | 756 | P06737 | |
| DIINMLFYHDRFKVF | 761 | P06737 | |
| MEEFFPETYRLDLKH | 281 | Q6ZVT0 | |
| DLLSMELPEFFRDYF | 151 | Q9H267 | |
| IMHLEEHLFCPYFFK | 211 | Q9HAW7 | |
| MFIKEDLILPHYHTF | 236 | Q9Y247 | |
| PFEYKEHDFRMAPKF | 1036 | Q14324 |